TherapeutAix NASH review article is now available online!
At the end of last year, TherapeutAix published an article titled ‘The future R&D landscape in non-alcoholic steatohepatitis’ in Drug…
TherapeutAix is heading to Massachusetts to attend MassBio Annual Meeting
MassBio is holding a ‘State of Possible Conference’ for 2 days on the 27-28th March in Cambridge, Massachusetts. The event…
TherapeutAix is speaking at the 18th Fraunhofer Seminar “Models of Lung Disease”
Darcey Black, Translational Director of TherapeutAix, will be speaking at the 18th Fraunhofer Seminar titled “Models of Lung Disease” on…
2018 Round Up – It’s a wrap
Since 2018 is quickly coming to an end, we look back at the past few months and reflect on all…
Navigating the NASH Maze
The availability of 2 approved medicines for the treatment of idiopathic pulmonary fibrosis (IPF) has stimulated an explosion in fibrosis…
